key: cord-1000368-twn3iayf
authors: Semelka, Charles T; Ornelles, David A; O’ Connell, Nathaniel S; Parsons, Emma C; Blevins, Maria W; Ivey, Lauren E; Bischoff, Werner E
title: Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics
date: 2021-03-06
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofab107
sha: a91d872b1ead12192a1c5e6092f3beeba9fdeae1
doc_id: 1000368
cord_uid: twn3iayf

Understanding transmission of SARS-CoV-2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.

A c c e p t e d M a n u s c r i p t 3 Background: Public health and infection control strategies regarding the pandemic are informed by our understanding of the spread of the SARS-CoV-2 virus. Viral spread, as defined by dispersion of viral particulates, correlates to the period of infectiousness for person-to-person transmission. 1 Viral load rapidly declines during the first week after symptom onset, and while shedding of viral particles may persist for several weeks, live virus has been cultured only early in the course of infection. 1, 2 The significance of transmission via aerosolized droplet nuclei (<5 μm in diameter), which may remain airborne as infectious particles for several hours has prompted investigation. [3] [4] [5] However, a metaanalysis described large respiratory droplets as the primary mode of transmission, in accordance with CDC guidelines. 2,6 Furthermore, certain patient characteristics and biomarkers have been associated with worse disease course and higher viral loads. 6, 7 With limited exceptions, the current literature infrequently describes patient clinical features associated with environmental detection of virus. 4 We measured the impact of source-control mask use and the associated patient clinical characteristics on environmental burden of SARS-CoV-2 in hospitalized patients.

This was a single-arm non-randomized control trial to study the effect of mask use Sample collection took place in hospital rooms with heating, ventilation and air conditioning (HVAC) systems exchanging room air 6 times per hour using MERV-14 filters with capacity to filter 90% of particles 1-3 microns in diameter. 8 Following enrollment a nasopharynx (NP) swab was obtained from each participant for viral load prior to air sampling. Andersen air A c c e p t e d M a n u s c r i p t 4 sampling devices and surface sedimentation plates were placed at three locations in patient hospital rooms ( Figure 1 ). To study the effect of source-control mask use on environmental contamination of virus, two 30-minute air sample runs were obtained for each study participant. During the first run, the patient was not wearing a mask, followed by a second run with patients wearing a non-medical 3-ply procedural mask (Haowei Weiye Technology Development, Harbin, China). Viral transport media (VTM) on sedimentation plates from Anderson air samplers were pooled from stages 1 and 2 (filter sizes >5 μm) and stages 3 -6 (filter sizes <5 μm) to separate large droplets from aerosols. Following a standard pattern, a 3 by 3 inch cutting from the center of patient masks was stored in VTM. Participants had 20 samples each: 9 samples from both environmental sampling runs (3 stations with 1 surface sample and 2 pooled samples from air sampling devices), patient mask and NP swab.

SARS-CoV-2 RNA was extracted from VTM, reverse transcribed into cDNA for viral amplification, and quantified by qPCR with CDC N1 and N2 detection assays. The viral load was reported as the threshold cycle (Ct), with lower Ct values representing higher viral loads. Our lower detection limit was approximately 75 viral genome copies per site measured, which falls below the infectious dose of coronaviruses. 9 Clinical characteristics including, comorbidities and biomarkers were recorded from the EHR and patient interview.

Using R statistical software, we assessed the association of NP viral load and days since symptom onset with positive detection in the mask or environment using 2-sample t-tests.

Random Forest imputation was used to impute two missing symptom onset values. We used Firth logistic regression in independent models to investigate the odds of positive detection of viral spread with clinical factors of interest (e.g. diabetes, hypertension, etc.), each controlling for days since symptom onset. This model accurately detects significance but is imprecise with magnitude of association in small samples.

The study population included 26 adults mean age 58.4 (SD, 15.9), male 62%, with comorbidities including hypertension 73%, obesity 62%, type 2 diabetes 46%, and heart disease 35%. Viral spread, as defined by detection of viral particulate dispersion in the A c c e p t e d M a n u s c r i p t 5 patient mask or environment, was present in 11 of 26 patients (42%) ( Table 1 ). Viral particles in large respiratory droplets were recovered adjacent to the head from 2 of 26 patients (8%; droplet sizes >5 um) who were closer to symptom onset (2 and 4 days). No aerosol sized particles were detected in air samplers for masked or unmasked runs. No virus was recovered from air samplers or surface plates from runs with patients wearing masks. 

In a limited sample of n=26 hospitalized patients, SARS-CoV-2 was detected only within large respiratory droplet range in unmasked patients (≤2 ft from head of patient), using air sampling methods validated on airborne viruses. 10 These findings support the use of contact and droplet precautions in routine clinical scenarios in hospitals. We demonstrated patient mask use stopped environmental dispersion of virus over 30-minute collections, which confirms low risk of viral transmission from infected hosts while using masks. 11 Viral load (Ct ≤25) followed by shorter duration from symptom onset (≤8 days), had the strongest association with spread of viral particles, which supports recent CDC strategies for decreased quarantine time following infection. 12 Clinical factors associated with severe disease course were linked to viral spread including, diabetes, M a n u s c r i p t M a n u s c r i p t 8 M a n u s c r i p t A c c e p t e d M a n u s c r i p t

Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature medicine

Transmission of SARS-CoV-2: a review of viral, host, and environmental factors

Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1

CDC. How COVID-19 Spreads

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

What is a MERV rating?

Schr der . C D-19: A Risk Assessment Perspective

Detection of Measles Virus RNA in Air and Surface Specimens in a Hospital Setting

Among Patients Exposed to Infected Healthcare Workers

Options to Reduce Quarantine for Contacts of Persons with SARS-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing

A c c e p t e d M a n u s c r i p t 7